1834 Investment Advisors’s Alkermes ALKS Stock Holding History

1834 Investment Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-218	Closed	-$5K	–	456
2019 Q2	$5K	Buy	+218	New	+$5.98K	﹤0.01%	398

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

1834 Investment Advisors's ALKS Position: Q3 2019 in Review

1834 Investment Advisors sold out of Alkermes (ALKS) in Q3 2019, closing a stake of 218 shares — an estimated $5K sold.

1834 Investment Advisors first reported a position in ALKS in Q2 2019 and held it in 1 quarter. The position peaked at $5K in Q2 2019. 202 funds tracked by Wall St. Rank hold ALKS as of Q3 2019.

1834 Investment Advisors reported no remaining Alkermes position as of Q3 2019 after selling out during the quarter.
1834 Investment Advisors sold 218 Alkermes shares in Q3 2019, an estimated $5K.
1834 Investment Advisors first reported a position in Alkermes in Q2 2019 and held it in 1 quarter.
1834 Investment Advisors's Alkermes position peaked at $5K in Q2 2019.
202 funds tracked by Wall St. Rank held Alkermes as of Q3 2019.

Based on 1834 Investment Advisors's 13F filing for Q3 2019, filed 31 Oct 2019.